The production of which of the following hormones is increased in obesity?

Explanation

## Correct Answer: A. Insulin Obesity is fundamentally a state of **insulin resistance and hyperinsulinemia**. The increased adipose tissue mass in obese individuals produces excess free fatty acids and inflammatory cytokines (TNF-α, IL-6), which impair insulin signaling at the receptor and post-receptor level. In response, the pancreatic β-cells compensate by increasing insulin secretion to maintain euglycemia—a hallmark feature of obesity. This hyperinsulinemia is one of the earliest metabolic abnormalities in obesity and precedes the development of type 2 diabetes mellitus. Fasting insulin levels are significantly elevated in obese individuals compared to lean controls, and this hyperinsulinemia drives further weight gain through increased lipogenesis and decreased lipolysis. The chronic elevation of insulin is a direct consequence of the body's attempt to overcome peripheral insulin resistance caused by excess adiposity. This is a cardinal feature taught in Indian endocrinology curricula and is central to understanding the metabolic syndrome, which is increasingly prevalent in urban Indian populations. ## Why the other options are wrong **B. Thyroxine** — Thyroxine (T4) production is typically **normal or decreased** in simple obesity. While metabolic rate may be altered, TSH and free T4 levels remain within normal range in uncomplicated obesity. Hypothyroidism can *cause* obesity, but obesity does not increase thyroxine production. This is a common NBE trap—confusing the direction of causality. **C. Growth hormone** — Growth hormone secretion is **suppressed in obesity**, not increased. Elevated free fatty acids and hyperinsulinemia inhibit GH-releasing hormone (GHRH) and enhance somatostatin secretion. Obese individuals have lower 24-hour GH secretion and blunted GH response to stimuli. This option reverses the actual pathophysiology. **D. Adiponectin** — Adiponectin is an **adipokine whose levels are decreased in obesity**, not increased. Despite increased adipose tissue mass, adiponectin production per unit of adipose tissue is reduced, leading to low circulating adiponectin levels. This paradox is a key feature of obesity-related metabolic dysfunction and is often tested in NEET PG. ## High-Yield Facts - **Hyperinsulinemia** is the earliest detectable metabolic abnormality in obesity, preceding hyperglycemia by years. - Obesity causes **insulin resistance** through increased free fatty acids, TNF-α, and IL-6 from adipose tissue. - **Adiponectin levels are paradoxically low** in obesity despite increased adipose tissue mass. - **Growth hormone secretion is suppressed** in obesity due to elevated free fatty acids and hyperinsulinemia. - **Thyroxine levels remain normal** in uncomplicated obesity; hypothyroidism is a cause, not a consequence, of obesity. ## Mnemonics **OBESITY HORMONES (What ↑ and ↓)** **↑ INSULIN** (hyperinsulinemia from IR), **↓ GH** (suppressed), **↓ Adiponectin** (paradoxical), **Normal T4** (unless primary hypothyroidism). Use this to eliminate wrong options quickly. **IR → Compensation → Hyperinsulinemia** Insulin Resistance (from excess FFA & cytokines) → β-cell Compensation → Hyperinsulinemia. This chain is the foundation of obesity pathophysiology in Indian endocrinology teaching. ## NBE Trap NBE pairs obesity with multiple hormone options to test whether students confuse causality (hypothyroidism causes obesity, not vice versa) and whether they know that adiponectin is *decreased* despite increased adipose tissue—a counterintuitive fact that trips many candidates. ## Clinical Pearl In Indian clinical practice, screening obese patients (BMI >25 kg/m²) with fasting insulin levels helps identify insulin resistance early—often before HbA1c rises. This is why many Indian diabetes centers now recommend insulin resistance assessment in all obese individuals, as it predicts progression to type 2 diabetes and metabolic syndrome. _Reference: Harrison Ch. 394 (Obesity); KD Tripathi Ch. 32 (Insulin & Metabolic Syndrome); Guyton Ch. 78 (Insulin Secretion)_